Molecular mechanism on functional food bioactives for anti-obesity

Current Opinion in Food Science

Volumn 2, Issue , 2015, Pages 9-13

  Lai, Ching Shu ^a   Wu, Jia Ching ^a   Pan, Min Hsiung ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84922879215     PISSN: 22147993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cofs.2014.11.008     Document Type: Review

References (41)

1. Tchernof A., Despres J.P. Pathophysiology of human visceral obesity: an update. Physiol Rev 2013, 93:359-404.
2. Bluher M. Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract Res Clin Endocrinol Metab 2013, 27:163-177.
3. Kushner R.F. Weight loss strategies for treatment of obesity. Prog Cardiovasc Dis 2014, 56:465-472.
4. Henry S.L., Bensley J.G., Wood-Bradley R.J., Cullen-McEwen L.A., Bertram J.F., Armitage J.A. White adipocytes: more than just fat depots. Int J Biochem Cell Biol 2012, 44:435-440.
5. Scott R., Tan T., Bloom S. Gut hormones and obesity: physiology and therapies. Vitam Horm 2013, 91:143-194.
6. Misra M. Obesity pharmacotherapy: current perspectives and future directions. Curr Cardiol Rev 2013, 9:33-54.
7. Kim G.W., Lin J.E., Blomain E.S., Waldman S.A. Antiobesity pharmacotherapy: new drugs and emerging targets. Clin Pharmacol Ther 2014, 95:53-66.
8. Williams D.J., Edward D., Hamernig I., Jian L., James A.P., Johnson S.K., Tapsell L.C. Vegetables containing phytochemicals with potential anti-obesity properties: a review. Food Res Int 2013, 52:323-333.
9. Baboota R.K., Bishnoi M., Ambalam P., Kondepudi K.K., Sarma S.M., Boparai R.K., Podili K. Functional food ingredients for the management of obesity and associated co-morbidities? A review. J. Funct. Foods 2013, 5:997-1012.
10. Trigueros L., Pena S., Ugidos A.V., Sayas-Barbera E., Perez-Alvarez J.A., Sendra E. Food ingredients as anti-obesity agents: a review. Crit Rev Food Sci Nutr 2013, 53:929-942.
11. Borriello A., Bencivenga D., Caldarelli I., Tramontano A., Borgia A., Zappia V., Della R.F. Resveratrol: from basic studies to bedside. Cancer Treat Res 2014, 159:167-184.
12. Park S.J., Ahmad F., Philp A., Baar K., Williams T., Luo H., Ke H., Rehmann H., Taussig R., Brown A.L., et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012, 148:421-433.
13. Knop F.K., Konings E., Timmers S., Schrauwen P., Holst J.J., Blaak E.E. Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects. Diabet Med 2013, 30:1214-1218.
14. Liu C.Y., Huang C.J., Huang L.H., Chen I.J., Chiu J.P., Hsu C.H. Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial. PLoS One 2014, 9:e91163.
15. Walsh A.M., Sweeney T., Bahar B., O'Doherty J.V. Multi-functional roles of chitosan as a potential protective agent against obesity. PLoS One 2013, 8:e53828.
16. Hsieh Y.L., Yao H.T., Cheng R.S., Chiang M.T. Chitosan reduces plasma adipocytokines and lipid accumulation in liver and adipose tissues and ameliorates insulin resistance in diabetic rats. J Med Food 2012, 15:453-460.
17. Liu S.H., Huang Y.W., Wu C.T., Chiu C.Y., Chiang M.T. Low molecular weight chitosan accelerates glucagon-like peptide-1 secretion in human intestinal endocrine cells via a p38-dependent pathway. J Agric Food Chem 2013, 61:4855-4861.
18. Alen F., Ramirez-Lopez M.T., Gomez de H.R., Rodriguez de F.F., Orio L. Cannabinoid receptors and cholecystokinin in feeding inhibition. Vitam Horm 2013, 92:165-196.
19. Assini J.M., Mulvihill E.E., Huff M.W. Citrus flavonoids and lipid metabolism. Curr Opin Lipidol 2013, 24:34-40.
20. Kim H.Y., Park M., Kim K., Lee Y.M., Rhyu M.R. Hesperetin stimulates cholecystokinin secretion in enteroendocrine STC-1 cells. Biomol Ther (Seoul) 2013, 21:121-125.
21. Park M., Kim K., Lee Y.M., Rhyu M.R., Kim H.Y. Naringenin stimulates cholecystokinin secretion in STC-1 cells. Nutr Res Pract 2014, 8:146-150.
22. Colitti M., Grasso S. Nutraceuticals and regulation of adipocyte life: premises or promises. Biofactors 2014, 10.1002/biof.1164.
23. li-Youcef N., Mecili M., Ricci R., Andres E. Metabolic inflammation: connecting obesity and insulin resistance. Ann Med 2013, 45:242-253.
24. Behloul N., Wu G. Genistein: a promising therapeutic agent for obesity and diabetes treatment. Eur J Pharmacol 2013, 698:31-38.
25. Bradford P.G. Curcumin and obesity. Biofactors 2013, 39:78-87.
26. Wang S., Moustaid-Moussa N., Chen L., Mo H., Shastri A., Su R., Bapat P., Kwun I., Shen C.L. Novel insights of dietary polyphenols and obesity. J Nutr Biochem 2014, 25:1-18.
27. Lai C.S., Ho M.H., Tsai M.L., Li S., Badmaev V., Ho C.T., Pan M.H. Suppression of adipogenesis and obesity in high-fat induced mouse model by hydroxylated polymethoxyflavones. J Agric Food Chem 2013, 61:10320-10328.
28. Zhang C.H., Yu R.Y., Liu Y.H., Tu X.Y., Tu J., Wang Y.S., Xu G.L. Interaction of baicalin with berberine for glucose uptake in 3T3-L1 adipocytes and HepG2 hepatocytes. J Ethnopharmacol 2014, 151:864-872.
29. Most J., Goossens G.H., Jocken J.W., Blaak E.E. Short-term supplementation with a specific combination of dietary polyphenols increases energy expenditure and alters substrate metabolism in overweight subjects. Int J Obes (Lond) 2014, 38:698-706.
30. Zhang Y., Huang C. Targeting adipocyte apoptosis: a novel strategy for obesity therapy. Biochem Biophys Res Commun 2012, 417:1-4.
31. Hahm J.R., Noh H.S., Ha J.H., Roh G.S., Kim D.R. Alpha-lipoic acid attenuates adipocyte differentiation and lipid accumulation in 3T3-L1 cells via AMPK-dependent autophagy. Life Sci 2014, 100:125-132.
32. Guo L., Huang J.X., Liu Y., Li X., Zhou S.R., Qian S.W., Liu Y., Zhu H., Huang H.Y., Dang Y.J., Tang Q.Q. Transactivation of Atg4b by C/EBPbeta promotes autophagy to facilitate adipogenesis. Mol Cell Biol 2013, 33:3180-3190.
33. Pan M.H., Lai C.S., Wu J.C., Ho C.T. Epigenetic and disease targets by polyphenols. Curr Pharm Des 2013, 19:6156-6185.
34. Lee J.E., Ge K. Transcriptional and epigenetic regulation of PPARgamma expression during adipogenesis. Cell Biosci 2014, 4:29.
35. Peng Y., Yu S., Li H., Xiang H., Peng J., Jiang S. MicroRNAs: emerging roles in adipogenesis and obesity. Cell Signal 2014, 26:1888-1896.
36. de M., Pulkkinen V., Lalli L., Kolehmainen M., Pihlajamaki M., Uusitupa J.M. DNA methylation in obesity and type 2 diabetes. Ann Med 2014, 46:103-113.
37. Zhou Y., Rui L. Leptin signaling and leptin resistance. Front Med 2013, 7:207-222.
38. Lorente-Cebrian S., Costa A.G., Navas-Carretero S., Zabala M., Martinez J.A., Moreno-Aliaga M.J. Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence. J Physiol Biochem 2013, 69:633-651.
39. Shen W., Wang C., Xia L., Fan C., Dong H., Deckelbaum R.J., Qi K. Epigenetic modification of the leptin promoter in diet-induced obese mice and the effects of N-3 polyunsaturated Fatty acids. Sci Rep 2014, 4:5282.
40. Boque N., de l I., de la Garza A.L., Milagro F.I., Olivares M., Banuelos O., Soria A.C., Rodriguez-Sanchez S., Martinez J.A., Campion J. Prevention of diet-induced obesity by apple polyphenols in Wistar rats through regulation of adipocyte gene expression and DNA methylation patterns. Mol Nutr Food Res 2013, 57:1473-1478.
41. Kang I., Okla M., Chung S. Ellagic acid inhibits adipocyte differentiation through coactivator-associated arginine methyltransferase 1-mediated chromatin modification. J Nutr Biochem 2014, 25:946-953.